Designing Growth Strategies is in our DNA

Specialty Drugs Market Size, Share & Industry Analysis, By Molecule Platform (Biologics, Specialty Small Molecules, Cell & Gene Therapies, Radiopharmaceuticals, and Others), By Disease Indication (Oncology, Autoimmune & Inflammatory Disorders, Rare Diseases/Orphan Disorders, Neurology, Hematology, Infectious Diseases, and Others), By Formulation (Oral and Parenteral {Intravenous (IV), Subcutaneous (SC), Intramuscular (IM), and Others}), By End User (Hospitals, Specialty Clinics & Infusion Centers, Home Care / Home Infusion, and Others), and Regional Forecast, 2026-2034

Last Updated :May 15, 2026 | Format:PDF | Report ID: 116144

 

Request Sample PDF

man icon
Mail icon
Captcha refresh
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 198